Latest On Aurora Cannabis Inc (ACB):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-04-25 02:30 EST | News | Aurora Cannabis repurchases $16.6M of senior notes to save on interest payments | N/A |  |
| 2023-04-22 04:48 EST | News | Cannabis reformer Sen. Cory Booker calls marijuana ‘a dangerous drug’ | N/A | |
| 2023-04-14 22:01 EST | News | Cannabis reformist Sen. Cory Booker calls marijuana ‘a dangerous drug’ | N/A | |
| 2023-03-31 16:31 EST | News | Aurora Cannabis repurchased a portion of convertible notes at a 2.5% discount to par value, maintains strong balance sheet | N/A | |
| 2023-03-27 11:01 EST | News | Aurora Cannabis receives non-compliance notice from Nasdaq | N/A | |
About Aurora Cannabis Inc (ACB):
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products read more...at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
General
- Name Aurora Cannabis Inc
- Symbol ACB
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 2,731
- Last Split Factor1:12
- Last Split Date2020-05-11
- Fiscal Year EndJune
- IPO Date2014-07-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://auroramj.com
Valuation
- Trailing PE 46.3
- Price/Sales (Trailing 12 Mt.) 5.75
- Price/Book (Most Recent Quarter) 1.19
- Enterprise Value Revenue 7.6
Financials
- Most Recent Quarter 2020-12-31
- Return on Assets -6%
- Return on Equity -80%
- Earnings Per Share $0.22
- Revenue Per Share $0
- Gross Profit -33539000
- Quarterly Earnings Growth 22.7%
Highlights
- Market Capitalization 1.97 billion
- PE Ratio -0.25
- Book Value Per Share $3.44
Share Statistics
- Shares Outstanding 197.39 million
- Shares Float 196.8 million
- % Held by Insiders 20%
- % Held by Institutions 14.14%
- Shares Short 20.23 million
- Shares Short Prior Month 25.89 million
- Short Ratio 0.65
- Short % of Shares Outstanding 10%
Technicals
- Beta 3.11
- 52 Week High $19.25
- 52 Week Low $3.71
- 50 Day Moving Average 11.89
- 200 Day Moving Average 8.81
Dividends
- Dividend Date 2020-05-11
- ExDividend Date N/A
- Dividend Yield 0%
Aurora Cannabis Inc (ACB) Dividend Calendar:
ACB's last dividend payment was made to shareholders on May 11, 2020.
Aurora Cannabis Inc (ACB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Aurora Cannabis Inc (ACB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Aurora Cannabis Inc (ACB) Chart:
Aurora Cannabis Inc (ACB) News:
Below you will find a list of latest news for Aurora Cannabis Inc (ACB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aurora Cannabis Inc (ACB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest ACB Trades:
Aurora Cannabis Inc (ACB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-02 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-30 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-29 | F-10/A (Registration Statement for Securities of certain Canadian Issuers.) | |
| 2020-10-27 | F-10 (Registration Statement for Securities of certain Canadian Issuers.) | |
| 2020-10-27 | F-X (Appointment of Agent for Service of Process and Undertaking) | |
| 2020-10-27 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-01 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-30 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-25 | 40-F (Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]) | |
| 2020-09-22 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-14 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-11 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-08 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-08 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-07-06 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-06-30 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-06-30 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-06-29 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-06-24 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-06-23 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |